Fall 2013 Newsletter
The National Center for Advancing Translational Sciences (NCATS) is promoting partnerships with industry to accelerate the development of new therapeutics. YCCI has embraced this concept by partnering with the Office of Cooperative Research (OCR) on pilot awards for promising translational projects that may ultimately become commercial products. We are also working with the Yale Entrepreneurial Institute (YEI) to bring new funding opportunities to the attention of investigators. YEI offers a number of opportunities related to research and boasts a staff with both scientific and business know-how. YCCI and YEI co-sponsored a symposium this fall on SBIR and STTR grants that sheds light on negotiating these programs. We hope that these efforts will speed up the process of bringing innovative discoveries from the lab to the clinic.
YCCI has been collaborating with Yale’s Office of Cooperative Research (OCR) to accelerate the translation of research discoveries from the laboratory to patients. The OCR partners with faculty members to determine the commercial potential of their inventions and discoveries. OCR also protects intellectual property by filing patents for faculty inventions; licenses faculty technology; and connects researchers with commercial partners.
Today’s research landscape is hemmed in by requirements that can be both confusing and onerous. In order to promote the highest quality of clinical research and to help investigators meet the intensified demands of regulatory agencies, YCCI is increasing its offerings of educational programs regarding compliance as well as expanding its compliance support staff.
The 2013 Office of Inspector General(OIG) Work Plan has been released by the U.S. Department of Health and Human Services(HHS). The OIG is responsible for detecting and preventing fraud, waste, and abuse among 300+ programs administered by the HHS, as well as maintaining and improving the operations of the programs.
On August 28, 2013, the United States Attorneys’ Office announced that Emory University agreed to pay the United States and the State of Georgia $1.5 million to resolve allegations of submitting false claims to Medicare and Medicaid from 2001 through 2010. According to the settlement agreement, Emory’s Winship Cancer Institute was accused of violating the National Coverage Determination (NCD) for Routine Costs in Clinical Trials through:
The rollout of epic and the continued implementation of OnCore, Yale’s clinical research management system (CRMS), are paving the way to an integrated information technology environment that fully supports research.